NIRACLE

Previously known as Nirvation, NiRACLE, LLC was founded in 2009 by Dr. Weiyong Li who has more than 20 years of experience in formulation an PAT technology, especially using Near Infrared as tool. After partnering with more scientific and business talents, Nirvation became NiRACLE in 2011... Founded in 2009 ( as Nirvation), NiRACLE is an innovative Contract Research Organization (CRO), providing Near Infrared (NIR) method development, Process Analytical Technology (PAT), Quality by Design (QbD), and process validation support to the pharmaceutical industry. NiRACLE has pioneered the Supervised Principal Component Analysis (SPCA) technology, a novel multivariate data analysis approach that can be used in NIR-related quantitative analysis (US Patent No. US2011/ 0216313 A1)... NiRACLE maintains strict confidentiality to our client's product R&D programs. Our capability will increase the probability of achieving your next key milestones (new drug product approving). We understand exactly..

Also known as: Niracle, LLC